FR05C0022I1 - - Google Patents

Info

Publication number: FR05C0022I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

2005-05-09

Publication date

2005-06-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR05C0022(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

2005-05-09 Application filed filed Critical

2005-06-10 Publication of FR05C0022I1 publication Critical patent/FR05C0022I1/fr

2005-10-21 Application granted granted Critical

2005-10-21 Publication of FR05C0022I2 publication Critical patent/FR05C0022I2/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Cephalosporin Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)

FR05C0022C 1995-03-30 2005-05-09 Active FR05C0022I2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en)	1995-03-30	1996-03-28	Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number	Publication Date
FR05C0022I1 true FR05C0022I1 (en)	2005-06-10
FR05C0022I2 FR05C0022I2 (en)	2005-10-21

Family

ID=26306774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR05C0022C Active FR05C0022I2 (en)	1995-03-30	2005-05-09

Country Status (35)

Country	Link
US (1)	US6417191B1 (en)
EP (1)	EP0817637B1 (en)
JP (1)	JP2954357B2 (en)
KR (1)	KR100542536B1 (en)
CN (1)	CN1103593C (en)
AP (1)	AP652A (en)
AT (1)	ATE220551T1 (en)
AU (1)	AU715213B2 (en)
BR (3)	BR9607851B1 (en)
CA (1)	CA2216634C (en)
CZ (1)	CZ295940B6 (en)
DE (3)	DE69622386T2 (en)
DK (1)	DK0817637T3 (en)
EA (1)	EA000626B3 (en)
EE (1)	EE04047B1 (en)
ES (1)	ES2179193T3 (en)
FR (1)	FR05C0022I2 (en)
GE (1)	GEP20022647B (en)
HU (1)	HU224010B1 (en)
IL (1)	IL117727A (en)
LU (1)	LU91171I2 (en)
MX (1)	MX9707316A (en)
MY (1)	MY115461A (en)
NL (1)	NL300195I2 (en)
NO (2)	NO313787B1 (en)
NZ (1)	NZ306419A (en)
OA (1)	OA10616A (en)
PL (1)	PL187085B1 (en)
PT (1)	PT817637E (en)
RO (1)	RO117995B1 (en)
SI (1)	SI0817637T1 (en)
SK (1)	SK283825B6 (en)
TR (1)	TR199701074T1 (en)
UA (1)	UA60293C2 (en)
WO (1)	WO1996030025A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0938321B1 (en) *	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
EP0979082A1 (en) *	1997-05-17	2000-02-16	Glaxo Group Limited	Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
WO1999060988A2 (en) *	1998-05-29	1999-12-02	University Of Florida	Combination therapy for treatment of fiv infection
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
TW200403061A (en) *	2002-06-04	2004-03-01	Glaxo Group Ltd	Pharmaceutical compositions
EA201100293A1 (en)	2003-01-14	2011-08-30	Джилид Сайэнс, Инк.	METHOD (OPTIONS) AND PHARMACEUTICAL COMPOSITION (OPTIONS) FOR THE TREATMENT OR PREVENTION OF THE SYMPTOMS OF HIV INFECTION
WO2004085406A1 (en)	2003-03-24	2004-10-07	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
CA2543490A1 (en)	2003-10-24	2005-05-06	Immunaid Pty Ltd	Method of analysing immune system cycling to monitor and/or treat diseases by the production of regulator t cells
TWI471145B (en)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	Unitary pharmaceutical dosage form
WO2007045573A1 (en)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
CA2671478C (en)	2006-12-13	2015-02-17	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
CA2677623C (en) *	2007-02-09	2015-04-07	Alphapharm Pty Ltd	A dosage form containing two or more active pharmaceutical ingredients in different physical forms
PT2435825E (en)	2009-05-27	2015-11-02	Biotempus Ltd	Methods of treating diseases
LT3127542T (en)	2010-01-27	2018-11-26	Viiv Healthcare Company	Antiviral therapy
WO2015028875A2 (en)	2013-08-29	2015-03-05	Teva Pharmaceuticals Industries Ltd.	Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
TW201622731A (en)	2014-04-08	2016-07-01	泰瓦藥品工業有限公司	Unit dosage form comprising Emtricitabine, Tenofovir, Darunavir and Ritonavir and a monolithic tablet comprising darunavir and ritonavir
CN112430250A (en)	2014-08-12	2021-03-02	莫纳什大学	Lymphatic prodrugs
EP3347340A4 (en)	2015-09-08	2019-01-23	Monash University	PROMOTERS TARGETING THE LYMPH
EP4306524A3 (en) *	2017-08-29	2024-09-11	PureTech LYT, Inc.	Lymphatic system-directing lipid prodrugs
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
US20210268115A1 (en)	2020-02-05	2021-09-02	Puretech Lyt, Inc.	Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) *	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en) *	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
ATE131730T1 (en)	1991-05-16	1996-01-15	Glaxo Group Ltd	ANTI-VIRUS PREPARATIONS CONTAINING NUCLEOSIDE ANALOGUES
WO1993023021A2 (en) *	1992-05-13	1993-11-25	The Wellcome Foundation Limited	Therapeutic combinations
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
CZ429398A3 (en)	1996-06-25	1999-05-12	Glaxo Group Limited	Combination of active compounds and pharmaceutical composition containing thereof
EP0938321B1 (en)	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
DE10226522A1 (en)	2002-06-14	2003-12-24	Degussa	Use of transition metal complexes with nitrogen-containing multidentate ligands as a bleaching catalyst and bleaching agent composition

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/en unknown
- 1996-03-28 NZ NZ306419A patent/NZ306419A/en not_active IP Right Cessation
- 1996-03-28 SI SI9630494T patent/SI0817637T1/en unknown
- 1996-03-28 SK SK1295-97A patent/SK283825B6/en not_active IP Right Cessation
- 1996-03-28 DE DE69622386T patent/DE69622386T2/en not_active Expired - Lifetime
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 EA EA199700203A patent/EA000626B3/en not_active IP Right Cessation
- 1996-03-28 PT PT96911953T patent/PT817637E/en unknown
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/en active IP Right Grant
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 RO RO97-01795A patent/RO117995B1/en unknown
- 1996-03-28 HU HU9801571A patent/HU224010B1/en active Protection Beyond IP Right Term
- 1996-03-28 AT AT96911953T patent/ATE220551T1/en active
- 1996-03-28 JP JP8528931A patent/JP2954357B2/en not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/en unknown
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en active IP Right Grant
- 1996-03-28 CN CN96194050A patent/CN1103593C/en not_active Expired - Lifetime
- 1996-03-28 ES ES96911953T patent/ES2179193T3/en not_active Expired - Lifetime
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/en not_active Expired - Lifetime
- 1996-03-28 MX MX9707316A patent/MX9707316A/en active IP Right Grant
- 1996-03-28 EE EE9700240A patent/EE04047B1/en not_active IP Right Cessation
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 DK DK96911953T patent/DK0817637T3/en active
- 1996-03-28 EP EP96911953A patent/EP0817637B1/en not_active Expired - Lifetime
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/en not_active IP Right Cessation
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/en not_active IP Right Cessation
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/en unknown
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/en active Pending
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/en active Active
- 1996-03-28 UA UA97094740A patent/UA60293C2/en unknown
- 1996-03-29 IL IL11772796A patent/IL117727A/en not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/en not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/en unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/en unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/en unknown

Also Published As

Publication number	Publication date
KR19980703420A (en)	1998-11-05
NL300195I2 (en)	2005-11-01
US6417191B1 (en)	2002-07-09
EP0817637A1 (en)	1998-01-14
PL187085B1 (en)	2004-05-31
JP2954357B2 (en)	1999-09-27
NO313787B1 (en)	2002-12-02
EA000626B3 (en)	2016-04-29
CN1103593C (en)	2003-03-26
IL117727A0 (en)	1996-07-23
EP0817637B1 (en)	2002-07-17
NO974510L (en)	1997-09-29
BR9607851B1 (en)	2009-01-13
BR9607851A (en)	1998-07-21
CZ309097A3 (en)	1998-05-13
HUP9801571A2 (en)	1999-01-28
NO2005014I1 (en)	2005-06-06
BRPI9612992B1 (en)	2020-08-04
NO974510D0 (en)	1997-09-29
DE69622386D1 (en)	2002-08-22
DK0817637T3 (en)	2002-11-11
AP9701089A0 (en)	1997-10-31
IL117727A (en)	1999-11-30
HU224010B1 (en)	2005-04-28
EA199700203A1 (en)	1998-02-26
DE69622386T2 (en)	2003-02-13
HUP9801571A3 (en)	2001-04-28
MY115461A (en)	2003-06-30
DE122005000029I1 (en)	2005-10-06
NO2005014I2 (en)	2008-02-11
BRPI9607851B8 (en)	2019-11-05
SI0817637T1 (en)	2002-10-31
MX9707316A (en)	1997-11-29
KR100542536B1 (en)	2006-03-23
FR05C0022I2 (en)	2005-10-21
UA60293C2 (en)	2003-10-15
LU91171I2 (en)	2005-07-04
GEP20022647B (en)	2002-03-25
DE122005000029I2 (en)	2006-04-27
PL322532A1 (en)	1998-02-02
EA000626B1 (en)	1999-12-29
CA2216634A1 (en)	1996-10-03
RO117995B1 (en)	2002-12-30
HK1009401A1 (en)	1999-09-10
AU715213B2 (en)	2000-01-20
EE04047B1 (en)	2003-06-16
CZ295940B6 (en)	2005-12-14
LU91171I9 (en)	2018-12-28
TR199701074T1 (en)	1998-02-21
NZ306419A (en)	2000-01-28
PT817637E (en)	2002-11-29
SK129597A3 (en)	1998-07-08
EE9700240A (en)	1998-04-15
CA2216634C (en)	2004-07-20
AP652A (en)	1998-06-19
OA10616A (en)	2001-03-15
ES2179193T3 (en)	2003-01-16
CN1185110A (en)	1998-06-17
NL300195I1 (en)	2005-08-01
AU5497296A (en)	1996-10-16
SK283825B6 (en)	2004-02-03
WO1996030025A1 (en)	1996-10-03
ATE220551T1 (en)	2002-08-15
JPH10511682A (en)	1998-11-10

Publication	Publication Date	Title
DE69638352D1 (en)	2011-05-19
DE69637714D1 (en)	2008-11-27
BR122012014331A2 (en)	1999-01-05
BRPI9612258B1 (en)	2011-05-31
BRPI9612138B1 (en)	2009-09-22
FR05C0022I2 (en)	2005-10-21
IN186887B (en)	2001-12-01
IN186501B (en)	2001-09-22
CH0741373H1 (en)	2011-10-14
IN182969B (en)	1999-08-14
DK0727898T3 (en)	1997-03-17
FR2729785B1 (en)	1997-02-21
AU697533B1 (en)	1997-04-10
IN182291B (en)	1999-03-13
BR7502120U (en)	1998-04-14
BR7501503U (en)	1997-11-25
IN182456B (en)	1999-04-17
IN185244B (en)	2000-12-09
IN186166B (en)	2001-06-30
AU1627395A (en)	1995-06-30
BY5258C1 (en)	2003-06-30
CN3030489S (en)	1995-03-08
CN3035870S (en)	1995-10-04
CN3038187S (en)	1995-12-06
CN3037606S (en)	1995-11-22